logo
Select company
Select metric
$ -0.53EBITDA per Share
VS
Market
23
Sector
58
Industry
21
History
75
$ 1.86Close
$ 1.3 - $ 2.95 52-Week Range
Ticker Information

Ticker

CPHI

Company Name

CHINA PHARMA HOLDINGS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NYSEMKT

CHINA PHARMA HOLDINGS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CPHI - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -1.74M$ -0.5313.26M
3/31/2025$ -2.21M$ -0.6813.26M
12/31/2024$ -1.96M$ -1.1211.75M
9/30/2024$ -1.7M$ -0.9811.73M
6/30/2024$ -1.35M$ -0.8311.61M
3/31/2024$ -454.86K$ -0.3511.31M
12/31/2023$ 8.44K$ 0.021338.36K
9/30/2023$ -34.02K$ -0.131264.33K
6/30/2023$ -28.22K$ -0.141198.32K
3/31/2023$ -362.83K$ -2.251161.58K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CHINA PHARMA HOLDINGS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -200.8.
  • Over the past 5 years, CHINA PHARMA HOLDINGS INC's average EBITDAPS has been $ -11.2.
  • The median EBITDAPS for CHINA PHARMA HOLDINGS INC during this period was $ -0.61
  • CHINA PHARMA HOLDINGS INC reached its highest EBITDAPS over the past 5 years at $ 2.5.
  • The lowest EBITDAPS recorded by CHINA PHARMA HOLDINGS INC in the same timeframe $ -200.8

CHINA PHARMA HOLDINGS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
INM : INMED PHARMACEUTICALS INC $ -7.43NBY : NOVABAY PHARMACEUTICALS INC $ 0.62BNBX : APPLIED DNA SCIENCES INC $ -22.47XBIO : XENETIC BIOSCIENCES INC $ -2NAOV : NANOVIBRONIX INC $ -8.93SHPH : SHUTTLE PHARMACEUTICALS HOLDINGS INC $ -10.5ISPC : ISPECIMEN INC $ -3.31ONCO : ONCONETIX INC $ -77.07SPRB : SPRUCE BIOSCIENCES INC $ -77.5WORX : SCWORX CORP $ -0.3

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for CHINA PHARMA HOLDINGS INC is calculated as follows: EBITDA [ $ -17.5M ] / (Shares WA [ 87.16K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -200.8 ]

CPHI - EBITDA per Share, Last 5 years

$ -200.8

Minimum

Sep 30, 2020

$ 2.5

Maximum

Dec 31, 2021

$ -11.2

Average

$ -0.61

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28